BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biotech Beach

  ROX Medical Announces Sustained Improvements in Patients With Uncontrolled Hypertension Treated With the ROX Coupler

  ROX Medical announced the publication of 12-month outcomes of the ROX CONTROL HTN study in the prestigious journal, Hypertension.

  October 26, 2017

   · 

  2 min read
• Business

  MyoKardia to Announce Third Quarter 2017 Financial Results on Thursday, November 2, 2017

  Management will host a conference call and live audio webcast at 4:30 p.m. ET to discuss these results and provide a business update.

  October 26, 2017

   · 

  2 min read
• Business

  Dendreon Strengthens Executive Team with Key Management Appointments

  Dendreon Pharmaceuticals today announced several key leadership appointments to further the company’s continued growth and expansion.

  October 26, 2017

   · 

  5 min read
• Business

  Veracyte to Host Conference Call and Webcast to Discuss Third Quarter 2017 Financial Results on Monday, November 6, 2017

  Veracyte announced today that it will report its third quarter 2017 financial results after the close of market on Monday, November 6, 2017.

  October 26, 2017

   · 

  1 min read
• Drug Development

  Proprietary Plasma-Generated Nitric Oxide Technology Being Developed at ADM Tronics for Origin Produces Positive Interim Results from Phase IIb Diabetic Foot Ulcer Study

  ADM Tronics Unlimited announced today that its client Origin has today announced positive interim results from its “GENESIS” US-based dose-ranging Phase IIb trial in the treatment of Diabetic Foot Ulcers utilizing a proprietary plasma technology.

  October 26, 2017

   · 

  4 min read
• Business

  Histogenics Corporation to Report Third Quarter 2017 Financial Results on November 9, 2017

  The Company will host a conference call and webcast at 8:30 a.m. ET to review financial and operational results for the quarter ended September 30, 2017 and provide a company update.

  October 26, 2017

   · 

  2 min read
• 

  Deals

  Ultragenyx and Dimension Announce Expiration of Hart-Scott-Rodino Waiting Period for Ultragenyx’s Acquisition of Dimension

  Ultragenyx and Dimension struck the m&a deal on October 2, 2017,

  October 26, 2017

   · 

  6 min read
• FDA

  Medinol Ltd. Receives CE Mark for the EluNIR Ridaforolimus-Eluting Coronary Stent System, and announces first commercial implantations

  Medinol announced that it obtained CE-mark for EluNIR, its novel Drug Eluting Stent featuring a unique stent design with low metal footprint and a proprietary elastomeric coating, both designed to optimize clinical outcomes.

  October 26, 2017

   · 

  3 min read
• Business

  Median Technologies Strengthens Its Medical Leadership With the Appointment of Dr. Loan Hoang-Sayag as Chief Medical Officer and the Appointment of Dr. Fabien Ricard as Medical Director, North America

  Median Technologies, The Imaging Phenomics Company announces the appointment of Dr. Loan Hoang-Sayag as Chief Medical Officer and the appointment of Dr. Fabien Ricard as Medical Director, North America.

  October 26, 2017

   · 

  5 min read
• Biotech Beach

  CureDuchenne Launches Virtual Durable Medical Equipment Expo for the Duchenne Community

  CureDuchenne, a nonprofit dedicated to funding research and improving patient care for Duchenne muscular dystrophy, launched the CureDuchenne Cares Virtual Durable Medical Equipment (DME) Expo as a resource for the Duchenne community.

  October 26, 2017

   · 

  2 min read